Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-24 @ 5:56 AM
Study NCT ID:
NCT02733250
Status:
COMPLETED
Last Update Posted:
2021-02-16
First Post:
2016-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer
Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-15
First Submit QC Date:
None
Study First Post Date:
2016-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-12
Last Update Post Date:
2021-02-16
Last Update Post Date Type:
ACTUAL